Sign Out
There is conclusive information as to whether Epirubicin may adversely affect human fertility or cause teratogenesis.
Experimental data, however, suggest that Epirubicin may harm the fetus and should, therefore, not be administered to pregnant women or to mothers who are breast feeding.
Continue with Google